News | May 02, 2026
Bayer pushes stroke prevention drug forward in China as regulators accept key filing
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
NEJM study shows strong protection across strains
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Subscribe To Our Newsletter & Stay Updated
